Log in

goodpods headphones icon

To access all our features

Open the Goodpods app
Close icon
Cancer ABCs  From Surviving To Thriving - How to Thrive with Cancer - Using The Genomic Health ARV-7 Test When You Are Taking Xtandi, Zytiga or Erleada

Using The Genomic Health ARV-7 Test When You Are Taking Xtandi, Zytiga or Erleada

Cancer ABCs From Surviving To Thriving - How to Thrive with Cancer

07/03/19 • 28 min

plus icon
Not bookmarked icon
Share icon

Written Transcript at:
https://www.cancerabcs.org/transcript-using-the-genomic-health-arv-7-test-when-you-arev-aking-xtandi-zytiga-or-erleada
In this podcast Anson Tharayanil, a Meical Science Liaison from Genomic Health, Inc. talks with Joel Nowak about their test, the Oncotype DX ARV-7 Nucleus Detect Test for men with castrate resistant metastatic prostate cancer.
The test is used to determine if the second line hormone therapies like Xtandi, Zytiga and Erleada will be an effective treatment for men who have the diagnosis of prostate cancer that has left the gland (if they have metastases) and are no longer responding to the first line hormone (ADT) treatments like Lupron, Eligard, Prostap and Casodex.
Initially, Anson gives an explanation about what is castrate resistant metastatic prostate cancer so that everyone can clearly understand the disease process that happens as prostate cancer progresses. Afterwards, he describes how the Oncotype DX ARV-7 Nucleus Detect Test works so that you can know if you are a candidate for any of the new second line hormone therapy drugs (Zytiga, Xtandi and Erleada).
Anson also describes how it might be possible to re-sensitive some men who have stopped responding to thee drugs.

Support the show

07/03/19 • 28 min

plus icon
Not bookmarked icon
Share icon

Cancer ABCs From Surviving To Thriving - How to Thrive with Cancer - Using The Genomic Health ARV-7 Test When You Are Taking Xtandi, Zytiga or Erleada

Transcript

Anson: So you can re-challenge your patient with Xtandi and Zytiga after using chemotherapy to take care of the prostate cancer that has become resistant.

MUSIC

Joel: Recently, we've been blessed with a number of new drugs that have received FDA approval. These drugs are specifically designed to treat men with what is called castrate-resistant metastatic prostate cancer. Unfortunately, these new drugs don't always work for all men and for those men for which the drugs do work, th

Episode Comments

0.0

out of 5

Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey IconStar filled grey Icon
Star filled grey IconStar filled grey Icon
Star filled grey Icon

No ratings yet

Star iconStar iconStar iconStar iconStar icon

eg., What part of this podcast did you like? Ask a question to the host or other listeners...

Post

Generate a badge

Get a badge for your website that links back to this episode

Select type & size
Open dropdown icon
share badge image

<a href="https://goodpods.com/podcasts/cancer-abcs-from-surviving-to-thriving-how-to-thrive-with-cancer-24700/using-the-genomic-health-arv-7-test-when-you-are-taking-xtandi-zytiga-869855"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to using the genomic health arv-7 test when you are taking xtandi, zytiga or erleada on goodpods" style="width: 225px" /> </a>

Copy